EMA (EU)
GUIDANCE FINAL
Guideline on data requirements for changes to the strain composition of authorised equine influenza vaccines in line with WOAH recommendations - Revision 1
Published: 7/24/2026Detected: 7/24/2026
Summary preview
Defines EMA data expectations to support authorized equine influenza vaccine strain composition updates when aligned with WOAH Expert Surveillance Panel recommendations, including removal, replacement, or addition of…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountimmunology
infectious_disease
respiratory
manufacturing
quality
clinical
safety
labeling
#equine influenza
#vaccine strain composition
#WOAH antigenic recommendations
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026